EmpiRx Health is redefining healthcare by proving it is possible to control drug spend while improving health outcomes
The FTC is expanding its ongoing study on pharmacy benefit managers (PBMs) and their impact on the accessibility and affordability of prescription drugs
Express Scripts is further aligning incentives across the pharmaceutical supply chain, consumers, and clients
The increase in drug prices has increased the attention on PBMs, and the role they play in drug pricing, both at the federal and state levels
New PBM contracting entities, often categorized as group purchasing organizations, add another obstacle to industry transparency
Employers’ benefit coverage decisions and the impact those decisions have on the market for rare disease / orphan drugs are a growing concern for biopharma companies
Mark Cuban Cost Plus Drug Company (Cost Plus Drugs) Joins the SmithRx Pharmacy Network
Prescryptive Health announced a partnership with Eli Lilly and Company on a subscription model to help lower costs for people who pay for their Lilly insulin through their employer-sponsored benefits